← Insider buys
OCUL

Ocular Therapeutix, Inc. · Healthcare

Chief Medical Officer Michael H. Goldstein bought $42K of Ocular Therapeutix, Inc.

Bought$41,500
$4.15Price
10,000Shares
+271%Stake

What OCUL did for a copier

Prices for OCUL after this filing aren't in yet.

Michael H. Goldstein's record

1 other buy on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, Mar 15. Filed Mon, Mar 18, 2:20 PM ET, during the session. Not investment advice.